Brian Lawson Appointed to Lead the Board of Pharmacy Specialties
The American Pharmacists Association (APhA) proudly announces the appointment of Brian Lawson, PharmD, ICE-CCP, as the Executive Director of the Board of Pharmacy Specialties (BPS). His selection comes after a thorough national search aimed at finding the best candidate to steer BPS into its future. Lawson's extensive background within BPS and the pharmacy profession positions him well for this leadership role.
Lawson's Journey and Expertise
Brian Lawson is not new to BPS; he has played a pivotal role within the organization for over a decade. Before this appointment, he served as the Interim Executive Director, showcasing his capabilities in management and leadership. He has occupied various senior-level positions, equipping him with comprehensive knowledge about the pharmacy landscape and the importance of board certification.
A Visionary Leader
“Dr. Lawson is a highly accomplished association management executive and credentialing leader,” stated Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, Executive Vice President and CEO of APhA. Lawson's innovative mindset and strategic vision have been instrumental in BPS's growth and evolution.
Expanding Global Reach
Since joining BPS in 2012, Lawson has demonstrated his leadership across several capacities, most recently as the Associate Executive Director. His efforts have significantly expanded BPS's global footprint, fortifying the organization’s governance and professional affairs. His experience on various national and international advisory boards has enabled him to contribute meaningfully to the advancement of pharmacy practice worldwide.
Commitment to Pharmacy Excellence
BPS stands as a leading certification body, with over 60,000 active pharmacist certifications spanning 15 specialties. Lawson’s appointment signals a strong commitment to not only maintain but also enhance the standards of pharmacy board certification. His plan is to build upon this solid foundation, furthering the mission to certify skilled pharmacists dedicated to improving patient care and clinical excellence.
Transition of Leadership
Lawson takes over from William Ellis, who retired after 12 years of dedicated service as Executive Director. Under Ellis's leadership, BPS achieved significant milestones, and Lawson’s task will be to continue this legacy while implementing new strategies to address the challenges faced by the pharmacy profession today.
Learn More About BPS
The Board of Pharmacy Specialties plays a vital role in the pharmacy landscape, actively working to enhance the quality of healthcare through board certification. To learn more about how BPS is advancing the future of pharmacy, please visit www.bpsweb.org. Additionally, for insights on the APhA and its continual efforts to foster the pharmacy profession, check out www.pharmacist.com.
SOURCE American Pharmacists Association
Frequently Asked Questions
What position has Brian Lawson been appointed to?
Brian Lawson has been named the Executive Director of the Board of Pharmacy Specialties.
What is the Board of Pharmacy Specialties?
The Board of Pharmacy Specialties (BPS) is a leading certification body for pharmacists, focusing on advancing board certification in the pharmacy profession.
Who did Brian Lawson succeed?
Lawson succeeded William Ellis, who retired after serving as Executive Director for 12 years.
What impact has Lawson had on BPS prior to this role?
Lawson has expanded BPS's global presence and has been integral to its governance and professional affairs.
How many certifications does BPS manage?
BPS manages over 60,000 active pharmacist certifications across 15 different specialties.
